Markets:

Overview

News

Currencies

International

Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

25.03 +0.81 (+3.34%)

Streaming Delayed Price Updated: 9:53 AM EDT, Aug 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan

April 11, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer

March 29, 2022

From Biodesix, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

March 25, 2022

On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Biodesix's Return On Capital Employed Insights ↗

March 15, 2022

Biodesix (NASDAQ:BDSX) brought in sales totaling $7.22 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.36%, resulting in a loss of $13...

Via Benzinga

Recap: Biodesix Q4 Earnings ↗

March 14, 2022

Biodesix (NASDAQ:BDSX) reported its Q4 earnings results on Monday, March 14, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Preview: Biodesix's Earnings ↗

March 11, 2022

Biodesix (NASDAQ:BDSX) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 28, 2022

On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

March 24, 2022

On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market...

Via Benzinga

Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights

March 14, 2022

From Biodesix

Via Business Wire

Earnings Scheduled For March 14, 2022 ↗

March 14, 2022

Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...

Via Benzinga

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022

February 28, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix CEO Scott Hutton Named to The Healthcare Technology Report’s List of Top 25 Biotech CEOs in 2022

February 22, 2022

From Biodesix, Inc.

Via Business Wire

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited)

February 14, 2022

From Biodesix, Inc.

Via Business Wire

Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 09, 2022

From Biodesix, Inc.

Via Business Wire

64 Biggest Movers From Yesterday ↗

February 01, 2022

Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...

Via Benzinga

PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics

January 19, 2022

From PierianDx

Via Business Wire

Biodesix Announces the Launch of its GeneStrat NGS™ Test and the IQLung™ Testing Strategy with Unprecedented Time to Results

January 18, 2022

From Biodesix, Inc.

Via Business Wire

Insider Weekends: Co-Founder Of EverQuote Acquires $1.45 Million Worth Of Stock ↗

January 09, 2022

Reviewing the list of companies that were at a new 52 week high and the ones that had hit a fresh 52 week low last week, I was struck by just how many of the companies in the 52...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets ↗

January 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...

Via Benzinga

Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan

January 04, 2022

From Biodesix, Inc.

Via Business Wire

40 Biggest Movers From Friday ↗

January 03, 2022

Gainers Nutriband Inc. (NASDAQ: NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Property Office has fully issued its...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

December 23, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors

December 08, 2021

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer

November 18, 2021

From Biodesix, Inc.

Via Business Wire

Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer

December 01, 2021

From Biodesix

Via Business Wire

Biodesix, Inc. (BDSX) Q3 2021 Earnings Call Transcript ↗

November 16, 2021

BDSX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Biodesix Announces Third Quarter 2021 Results and Highlights

November 15, 2021

From Biodesix, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021 ↗

November 17, 2021

Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.